Sartorius Stedim Biotech SA
F:56S1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sartorius Stedim Biotech SA
F:56S1
|
FR |
|
V
|
Volkswagen AG
XHAM:VOW
|
DE |
|
S
|
Sierra Bancorp
NASDAQ:BSRR
|
US |
|
ANSYS Inc
NASDAQ:ANSS
|
US |
|
E
|
EOG Resources Inc
XBER:EO5
|
US |
|
A
|
American Express Co
F:AEC1
|
US |
|
C
|
Coty Inc
F:CO3A
|
US |
|
Equinor ASA
LSE:0A7F
|
NO |
|
Sartorius AG
F:SRT0
|
DE |
|
Sydbank A/S
OTC:SYANY
|
DK |
|
Evertec Inc
NYSE:EVTC
|
PR |
|
NVR Inc
NYSE:NVR
|
US |
|
Nel ASA
OSE:NEL
|
NO |
|
Siemens Energy India Ltd
NSE:ENRIN
|
IN |
|
Basf Se
OTC:BASFY
|
DE |
|
Fugro NV
AEX:FUR
|
NL |
|
Delta Air Lines Inc
NYSE:DAL
|
US |
|
S
|
Securitas AB
XBER:S7MB
|
SE |
|
BRP Group Inc
NASDAQ:BWIN
|
US |
|
A
|
Atoss Software AG
XHAM:AOF
|
DE |
Bankruptcy Probability
Sartorius Stedim Biotech SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Sartorius Stedim Biotech SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
17.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1.3T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
195.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Danaher Corp
NYSE:DHR
|
140.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
367.9B CNY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Lonza Group AG
SIX:LONN
|
40.2B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
64.6T KRW |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Agilent Technologies Inc
NYSE:A
|
38B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Waters Corp
NYSE:WAT
|
37B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
34.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Illumina Inc
NASDAQ:ILMN
|
28.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Sartorius Stedim Biotech SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Sartorius Stedim Biotech SA has total debt of 2B EUR. This includes both short-term (0 EUR) and long-term (2B EUR) debt.
You can find a full breakdown on its Balance Sheet.